NEW YORK, August 8, 2018 /PRNewswire/ --
According to data published by Forbes, Brightfield Group estimates that the global cannabis industry was worth USD 7.7 Billion at the end of 2017 and is projected to cross the USD 30 Billion
mark by 2021. The industry is expected to witness a compound annual growth rate (CAGR) of 60% as other countries liberalize their
cannabis laws. Earlier this year, California voted in favor of recreational cannabis laws, and
on June 19 th, Canada had legalized cannabis on a federal level. Currently, California is considered to be the largest market for cannabis, while the United
States itself accounts for about 90% of the whole market. However, its dominance is likely to decrease to about 57%, as
legalization and decriminalization of cannabis products continues in other nations. CLS Holdings USA Inc. (OTC: CLSH), Canopy Growth Corp. (NYSE: CGC), Hydropothecary Corp. (OTC: HYYDF), MedMen Enterprises
Inc. (OTC: MMNFF), Leafbuyer Technologies Inc. (OTC: LBUY)
The legal cannabis market has become highly competitive at a staggering speed. According to Brightfield Group's official blog
post, "With cannabis dispensary and product data now going back over two years, our surveys of marijuana product availability in
major US state markets reveal several clear indicators that the market is growing increasingly competitive and crowded… One
example of this is exhibited by the increase in the variety of branded products available at US dispensaries. Two years ago, the
average US dispensary carried 94 different types of branded marijuana products. One year ago, that number had grown to 118, and
by January of this year, a typical dispensary carried over 150 different branded products."
CLS Holdings USA Inc. (OTCQB: CLSH) yesterday announced breaking news that, "the
closing of a USD 3 Million equity investment from Navy Capital Green International Ltd., a cannabis-focused
institutional fund based in New York City. Under the terms of the agreement, Navy Capital and or select others may invest an
additional USD 2 Million, with a 15% overallotment, for a total of up to USD 5,750,000.00 by August 15th,
2018.
Navy Capital has a vast network of relationships in the cannabis industry and is extremely interested in the CLS patented
extraction and processing technology.
CLS now has all the funds in place to complete its build-out of its Las Vegas cultivation and production facility.
In addition, CLS will utilize a portion of the proceeds to update its existing Oasis Cannabis dispensary location and improve its
signage.
John Kaden, Managing Partner and Chief Investment Officer of Navy Capital, stated, 'We believe
CLS Holdings possesses the premier vertically-integrated cannabis business in Nevada and when combined with the
Company's opportunities in other major U.S. states and its cutting-edge scientific developments, we expect that CLS quickly will
establish itself as one of the top companies in the emerging U.S. cannabis market.'
Jeff Binder, Chief Executive Officer of CLS, commented, 'We look forward to the added value
that Navy Capital brings to CLS. It is a terrific corporate development to have an additional partner, of Navy Capital's stature,
and we are excited by the expertise they bring to CLS.'
About Navy Capital - Navy Capital's research-oriented, fundamentally-driven investment process focuses on identifying
attractive opportunities within the legal cannabis space. Navy Capital seeks to find the best in class businesses within key
verticals of the global cannabis industry. Those verticals include Consumer, Healthcare, Technology, Industrials,
and Agriculture. Navy Capital invests in 20-30 publicly traded and select private companies that will gain market
share over time in their respective verticals. Businesses that have recurring revenue and management teams that have a large
share of their net worth in the company and are deeply passionate about their culture and customers are the most attractive to
it. For additional information, please visit: https://www.navycapital.com
About Oasis Cannabis (http://oasiscannabis.com) - Oasis Cannabis has
operated a cannabis dispensary in the Las Vegasmarket since dispensaries first opened in Nevada in 2015 and has
been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip
and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals
and tourists in the Las Vegas area. The company recently commenced wholesale offerings of cannabis
in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products in August
2017. An expansion of its cultivation and production facility is currently underway and is expected to be completed during the
fourth quarter of 2018."
Canopy Growth Corp. (NYSE: CGC) is a world-leading diversified cannabis and hemp company, offering distinct brands and
curated cannabis varieties in dried, oil and Softgel capsule forms. The Company recently announced that it has completed the
previously announced acquisition of Canopy Health Innovations Inc. ("CHI"), including the subsidiary operations of Canopy Animal
Health Inc. ("CAH"). The Company believes its strategy of integrating and aligning CHI's clinical platform with the international
work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and
formulations and ultimately improve patient access to medical cannabis globally. CHI has built a diversified business focused on
unlocking the therapeutic and commercial potential of cannabis for both humans and animals. Incorporating CHI into this ecosystem
as a wholly-owned subsidiary will increase efficiencies and unlock the full potential of CHI's significant IP portfolio including
39 patent applications filed with the United States Patent Trade Office. "Canopy Growth continues to expand its medical cannabis
leadership around the globe with an ecosystem that includes world-class production and infrastructure, patient and healthcare
practitioner education, and robust clinical research," said Mark Zekulin, President & Co-Chief
Executive Officer, Canopy Growth.
Hydropothecary Corp. (OTC: HYYDF) creates and distributes innovative, easy-to-use and easy-to-understand products to
serve the Canadian cannabis market. The Company recently announced, along with Molson Coors
Canada, the Canadian business unit of Molson Coors Brewing Company, that they have entered into a definitive agreement to
form a joint venture to pursue opportunities to develop non-alcoholic, cannabis-infused beverages for the Canadian market
following legalization. "HEXO continues to lead the way for smoke-free cannabis innovation in Canada. We are excited about this partnership with Molson Coors Canada, an
iconic leader in adult beverages, as we embark on the journey of building a brand new market. With this new Company, we are
bringing together Quebec's oldest, most established Company with one of its newest success
stories in a truly innovative partnership," said HEXO's Chief Executive Officer and Co-Founder Sebastien
St-Louis. "As two leading Companies who share a track record of excellent practices, as well as respect for law and
regulations, HEXO and Molson Coors Canada have established a relationship built on trust, and
together we will develop responsible, high-quality cannabis-infused beverages for the consumable cannabis market in Canada."
MedMen Enterprises Inc. (OTCQB: MMNFF) is a leading cannabis company in the U.S. with assets and operations nationwide.
The Company recently announced that the New York Department of Health has approved MedMen's request to manufacture and sell
cannabis-infused lotions and topical pain-alleviating sprays for qualified medical marijuana patients. MedMen's four stores in
New York currently offer vaporizer pens, tinctures and gel caps in five different formulations.
Earlier this year, the state also approved MedMen adding ground flower in the form of metered pods to its product selection.
MedMen is one of only 10 companies licensed to manufacture and sell medical marijuana in New
York. In April, MedMen opened its flagship store on Fifth Avenue, only one of three licensed dispensaries in Manhattan. New York continues to expand its medical marijuana program. Recently, State Health Commissioner
Howard Zucker filed emergency regulations allowing cannabis as a substitute for opioids, making
medical marijuana legally accessible to patients currently using prescription opioids to treat severe pain. MedMen operates a
cultivation and manufacturing facility in Utica, New York and four dispensaries statewide.
Leafbuyer Technologies Inc. (OTCQB: LBUY) is one of the most comprehensive online sources for cannabis deals and
information. The Company recently announced that sales growth has increased by over 50% from Q4 2017 to Q4 2018. This growth
comes on the back of continued expansion into new markets as well as increased product offerings, such as online pre-ordering and
the Company's loyalty program. "Expansion plans started 9 months ago in Oregon, Washington, California, Nevada, and
Arizona, and we are capitalizing on those markets," said John
Valle, Director of Sales for Leafbuyer Technologies Inc. Valle went on to say, "We are pleased with our growth, and with
California continuing its transition from non-licensed shops to licensed shops, we believe we
are in a great position to work with those companies from day one."
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For CLS Holdings USA Inc. financial news
dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the
company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or
site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and
the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in
securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the
information on the editorial or Site or continue to post information about any companies the information contained herein is not
intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site,
company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors
accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation
of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and
website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time.
None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication
is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree
to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change
without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com